Dabigatran Etexilate (Pradaxa®) for the treatment of DVT and PE

Assessment Status NCPE Assessment Process Complete
Drug Dabigatran
Brand Pradaxa®
Indication For the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.
Assessment Process
NCPE assessment outcome Full Pharmacoeconomic Evaluation Not Recommended